Terumo Corp Unsp ADR (TRUMY) 19.6822 $TRUMY
SANS-Norse Cyberthreat Report Reveals that Cyberattacks Are Causing an Epidemic of Compromises at Healthcare Organizations
PR Newswire - Wed Feb 19, 7:00AM CST
Norse, a leading provider of live threat intelligence-based security solutions, in association with SANS, the most trusted and largest source for information security training, certification and research, today released the SANS-Norse Healthcare Cyberthreat Report. Senior SANS Analyst and Healthcare Specialist Barbara Filkins developed the report with intelligence gathered by the Norse global threat intelligence platform. The report reveals that the networks and Internet-connected devices of organizations in virtually every healthcare category -- from hospitals to insurance carriers to pharmaceutical companies -- have been and continue to be compromised by successful attacks. A network compromise often leads to a data breach, potentially exposing the personally identifiable information of millions of consumers as well as the organization's own intellectual property and billing systems. In addition, these compromised networks allow cybercriminals to use the organization's network infrastructure and devices to launch attacks on other networks and to execute billions of dollars worth of fraudulent transactions.
MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion
PR Newswire - Mon Jul 22, 9:00AM CDT
MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced earlier last week that they successfully completed their first enrollment in a multi-center, prospective, pivotal U.S. clinical trial to demonstrate the safety and efficacy of its FRED(TM) flow diversion system (FRED(TM)-Flow Re-Direction Endoluminal Device) for treating intracranial aneurysms. Intracranial aneurysms are an abnormal, outward bulging of an artery in the brain caused by weakness in the arterial wall.
Terumo Medical Corporation Obtains Withdrawal By Vascular Solutions Of The R-Band(TM) Radial Hemostasis Device
PR Newswire - Tue May 21, 3:05PM CDT
Terumo Medical Corporation (Terumo), today announced that it was pleased with the U.S. District Court for the District of New Jersey's Order approving an agreement of the parties under which Vascular Solutions Inc. will cease further manufacture, sales, and distribution of its R-Band(TM) Radial Hemostasis Device, pending litigation of Terumo's claims.
Heart repair breakthroughs replace surgeon's knife
By MARILYNN MARCHIONE - AP - Mon Mar 25, 12:40AM CDT
SAN FRANCISCO (AP) — Have a heart problem? If it's fixable, there's a good chance it can be done without surgery, using tiny tools and devices that are pushed through tubes into blood vessels.
MicroVention's New Manufacturing Plant Facility In Costa Rica Celebrates Grand Opening With Inaugural Plant Ceremony
PR Newswire - Wed Mar 06, 9:00AM CST
MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced that its new manufacturing facility in San Jose, Costa Rica is now open. The Company also held a Grand Opening Ceremony today to commemorate this exciting new venture for MicroVention. The new plant represents MicroVention's first manufacturing facility outside the United States and the first Neurovascular manufacturing facility in Costa Rica, which is located at the Coyol Free Zone in the Alajuela region of Costa Rica.
Terumo Medical Corporation Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology Company
PR Newswire - Tue Feb 19, 6:30AM CST
Terumo Medical Corporation (Terumo), today announced that it has filed a patent infringement lawsuit against Vascular Solutions Inc. and Lepu Medical Technology (Beijing) Co., Ltd in the U.S. District Court of New Jersey.
SANS-Norse Cyberthreat Report Reveals that Cyberattacks Are Causing an Epidemic of Compromises at Healthcare Organizations
PR Newswire - Wed Feb 19, 7:00AM CST
Norse, a leading provider of live threat intelligence-based security solutions, in association with SANS, the most trusted and largest source for information security training, certification and research, today released the SANS-Norse Healthcare Cyberthreat Report. Senior SANS Analyst and Healthcare Specialist Barbara Filkins developed the report with intelligence gathered by the Norse global threat intelligence platform. The report reveals that the networks and Internet-connected devices of organizations in virtually every healthcare category -- from hospitals to insurance carriers to pharmaceutical companies -- have been and continue to be compromised by successful attacks. A network compromise often leads to a data breach, potentially exposing the personally identifiable information of millions of consumers as well as the organization's own intellectual property and billing systems. In addition, these compromised networks allow cybercriminals to use the organization's network infrastructure and devices to launch attacks on other networks and to execute billions of dollars worth of fraudulent transactions.
MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion
PR Newswire - Mon Jul 22, 9:00AM CDT
MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced earlier last week that they successfully completed their first enrollment in a multi-center, prospective, pivotal U.S. clinical trial to demonstrate the safety and efficacy of its FRED(TM) flow diversion system (FRED(TM)-Flow Re-Direction Endoluminal Device) for treating intracranial aneurysms. Intracranial aneurysms are an abnormal, outward bulging of an artery in the brain caused by weakness in the arterial wall.
Terumo Medical Corporation Obtains Withdrawal By Vascular Solutions Of The R-Band(TM) Radial Hemostasis Device
PR Newswire - Tue May 21, 3:05PM CDT
Terumo Medical Corporation (Terumo), today announced that it was pleased with the U.S. District Court for the District of New Jersey's Order approving an agreement of the parties under which Vascular Solutions Inc. will cease further manufacture, sales, and distribution of its R-Band(TM) Radial Hemostasis Device, pending litigation of Terumo's claims.
Heart repair breakthroughs replace surgeon's knife
By MARILYNN MARCHIONE - AP - Mon Mar 25, 12:40AM CDT
SAN FRANCISCO (AP) — Have a heart problem? If it's fixable, there's a good chance it can be done without surgery, using tiny tools and devices that are pushed through tubes into blood vessels.
MicroVention's New Manufacturing Plant Facility In Costa Rica Celebrates Grand Opening With Inaugural Plant Ceremony
PR Newswire - Wed Mar 06, 9:00AM CST
MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced that its new manufacturing facility in San Jose, Costa Rica is now open. The Company also held a Grand Opening Ceremony today to commemorate this exciting new venture for MicroVention. The new plant represents MicroVention's first manufacturing facility outside the United States and the first Neurovascular manufacturing facility in Costa Rica, which is located at the Coyol Free Zone in the Alajuela region of Costa Rica.
Terumo Medical Corporation Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology Company
PR Newswire - Tue Feb 19, 6:30AM CST
Terumo Medical Corporation (Terumo), today announced that it has filed a patent infringement lawsuit against Vascular Solutions Inc. and Lepu Medical Technology (Beijing) Co., Ltd in the U.S. District Court of New Jersey.
